2-chloro-6alpha, 9-difluoro-11beta, 17,21-trihydroxy-16alpha-methylpregna-1,4-dien-3,20-dione,
C 48,401-Ba,
C-48,401-Ba,
halometasone,
halometasone monohydrate,
Sicorten,
HALOMETASONE,
50629-82-8,
Sicorten,
2-Chloroflumethasone,
HALOMETASONE MONOHYDRATE,
UNII-J69Z9UU41Z,
Halometasone [INN],
Halometasone hydrate,
J69Z9UU41Z,
Halometasone (INN),
Halometasona,
Halometasonum,
Halomethasone,
SMR000466330,
Halometasonum [INN-Latin],
Halometasona [INN-Spanish],
EINECS 256-664-9,
SCHEMBL4872,
MLS000759439,
MLS001424089,
CHEMBL1587228,
DTXSID1048382,
CHEBI:135724,
C 48401Ba,
HMS2051C16,
HMS2232N17,
ZINC3938673,
Ba 48401,
AKOS025402048,
AC-3528,
CCG-100880,
NC00130,
2-Chlor-6alpha,9-difluor-11beta,17,21-trihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dion,
AB2000751,
FT-0630636,
D07202,
AB00639905-06,
629H828,
Q-101370,
2-Chloro-6|A,9-difluoro-11|A,17,21-trihydroxy-16|A-methylpregna-1,4-diene-3,20-dione,
(6|A,11|A,16|A)-2-Chloro-6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione,
2-Chloro-6alpha,9-difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione,
Pregna-1,4-diene-3,20-dione, 2-chloro-6,9-difluoro-11,17,21-trihydroxy-16-methyl-, (6alpha,11beta,16alpha)-,
Sicorten (TN),
D0C8HR,
C22H27ClF2O5,
C22-H27-Cl-F2-O5,
CID9846332,
(6-alpha,11-beta,16-alpha)-2-Chloro-6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione,
(6|A,11|A,16|A)-2-Chloro-6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; 2-Chloroflumethasone; Ba 48401; C 48401Ba; Halomethasone; Sicorten; 2-Chloro-6|A,9-difluoro-11|A,17,21-trihydroxy-16|A-methylpregna-1,4-diene-3,20-dione,